| Literature DB >> 28793885 |
Rafael Rehwald1,2, Elisabeth Schönherr1, Johannes Petersen1, Hans-Christian Jeske3, Anna Fialkovska1, Anna Katharina Luger1, Astrid Ellen Grams4, Alexander Loizides1, Werner Jaschke1, Bernhard Glodny5.
Abstract
BACKGROUND: Angioembolization is the method of choice for treating haemorrhage after blunt pelvic trauma. The aim of this study was to determine technical factors related to endovascular procedures which might be related to patient outcome.Entities:
Keywords: Endovascular treatment; Haemorrhage; Pelvic trauma; Transarterial embolization
Mesh:
Year: 2017 PMID: 28793885 PMCID: PMC5551004 DOI: 10.1186/s12893-017-0283-1
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.102
Materials used for angiography and TAE
| Embolic agents | Manufacturer | Product | Structure | Size |
|
|---|---|---|---|---|---|
| Coils | Boston Scientific Corp. | IDC™ Interlocking Detachable Coils | nf | Micro | 40 |
| Interlock™ - 18 Fibered IDC™ Occlusion System | f | Micro | 4 | ||
| Interlock™ Coils | f | Micro | 65 | ||
| Interlock™ - 35 Fibered IDC™ Occlusion System | f | Macro | 4 | ||
| COOK® Medical | Detach-11™ Detach Embolization Coil System | nf | Micro | 98 | |
| Detach-18® Detach Embolization Coil System | nf | Micro | 12 | ||
| “MWCE” Embolization Coil | f | both | 3a/29b | ||
| ABC Embolization Microcoils™ | f | Micro | 7 | ||
| MReye® Embolization Coils (“0.035”) | f | Macro | 174 | ||
| Hilal Embolization Microcoils™ | f | Micro | 154 | ||
| MicroVention, Inc. | MicroPlex® Coil System | nf | Micro | 104 | |
| MicroTherapeutics, Inc. | “KA” family | nf | Micro | 4 | |
| “KB” family | nf | Micro | 1 | ||
| “KD” family | nf | Micro | 41 | ||
| “J” family | nf | Micro | 11 | ||
| Topaz family | nf | Micro | 12 | ||
| Dendron family | nf | Micro | 6 | ||
|
| - | - | - | 99 | |
| Particles | Boston Scientific Corp. | Contour™ PVA particles | - | - | 52 |
| Nycomed Amersham plc | Ultra Drivalon PVA particles | - | - | 5 | |
| BTG plc | BeadBlock® Embolic Device | - | - | 1 | |
|
| - | - | - | 4 | |
| Acrylic Glues | Ethicon, Inc. | Ethibloc® | - | - | 16 |
| GEM s.r.l | Lipiodol-Glubran 2® | - | - | 1 | |
|
| Lipiodol (only) | - | - | 3 | |
| Other | |||||
| Boston Scientific Corp. | FastTracker™ Microcatheter family | ||||
| Fathom™-16 | |||||
| Mustang™ Over-The-Wire Balloon Dilatation Catheter | |||||
| Renegade™ HI-FLO™ Microcatheter | |||||
| Renegade™ STC 18 Microcatheter | |||||
| Medi-Tech, Inc. | Occlusion Balloon Catheter | ||||
| Target Therapeutics, Inc. | Coil Pusher-10 | ||||
| Coil Pusher-14 | |||||
| Coil Pusher-16 | |||||
| Coil Pusher-18 | |||||
| TurboTracker-18 Infusion Catheter | |||||
| Codman & Shurtleff, Inc. | Prowler® Select® LP ES | ||||
| Cordis® | STABILIZER® Balance Performance Steerable Guidwire | ||||
| COOK® Medical | D.A.S.H.® Extractor Catheter | ||||
| Flexor® Introducer with small Check-Flo® Valve | |||||
| MicroFerret® - 18 Zeta Infusion Catheter | |||||
| ev3™ Inc. | Silverspeed™ Hydrophilic Guidewire “SilverSpeed-14” | ||||
| X-Pedion™ Hydrophilic Guidewire “X-Pedion 14” | |||||
| St. Jude Medical™, Inc. | AMPLATZER Vascular Plug II | ||||
TAE Tansarterial embolization
aMicrocoils
bMacrocoils
Other parameters assessed
| Admission |
| Injured Vessel |
| Cause of Accident |
| OTA |
|
|---|---|---|---|---|---|---|---|
| Emergency department | 53 | Internal pudendal artery | 29 | Hit by vehicle | 21 | A | 16 |
| Secondary | 48 | Obturator artery | 29 | Hit by heavy object | 15 | B | 46 |
| Casualty department | 11 | Superior gluteal artery | 28 | Fall from standing height | 15 | C | 40 |
| Internal iliac artery | 24 | Winter sport accident | 14 | Bruise | 10 | ||
| Discharge |
| Pudendal artery | 21 | ||||
| Home | 29 | Inferior gluteal artery | 15 | ||||
| Rehabilitation | 33 | Inferior epigastric artery | 11 | ||||
| ADL. external Hospitalization | 33 | Circumflex femoral artery | 10 | ||||
| Corona mortisa | 7 | ||||||
| Lubar arteries | 6 | ||||||
| Iliolumbar artery | 5 | ||||||
| Lateral sacral artery | 5 | ||||||
| Vesical arteries | 5 | ||||||
| Superficial femoral artery | 4 | ||||||
| External iliac artery | 2 | ||||||
| Gluteal artery | 2 | ||||||
ADL Additional
aAnastomosis between inferior epigastric artery and obturator artery
Fig. 1a and b: 3D Volume rendering. 3D volume rendering reconstructions of the initial CT scan prior to endovascular intervention in an anterior (a) and a posterior (b) view. Central acetabular dislocation fracture on the left side (OTA 62.B1.1), and unstable pelvic fracture (OTA 63.C1.3) with vertical sacral fracture and anterior pelvic ring disruption. Disruptions of the left superior gluteal and a sacral arteries with large extravasation of contrast material
Comparison of patient groups
| First group | Second group |
| |||
|---|---|---|---|---|---|
|
|
|
|
| ||
| Patients under 65 vs. over 65 years | |||||
| ISS | 27.9 ± 14.3 | 66 | 17.1 ± 13.3 | 46 | < 0.0001 |
| Surgical procedures | 2.2 ± 1.4 | 66 | 1.1 ± 1.1 | 46 | 0.0001 |
| Transfusion received | 44 yes / 22 no | 66 | 18 yes / 28 no | 46 | 0.0065 |
| Hb (g/l) | 89.6 ± 28.8 | 66 | 100.8 ± 23.6 | 46 | 0.0115 |
| Haematoma volume (ml) | 789.9 ± 484.0 | 66 | 614.0 ± 400.3 | 46 | 0.0325 |
| Hospitalization (days) | 34.6 ± 27.4 | 66 | 25.5 ± 27.1 | 46 | 0.0376 |
| Survival | 8 yes / 58 no | 66 | 9 yes / 37 no | 46 | 0.2974 |
| Male vs. Female patients | |||||
| Surgical procedures | 1.9 ± 1.4 | 72 | 1.4 ± 1.5 | 40 | 0.0393 |
| Duration trauma-angiography (min) | 393.7 ± 1088.0 | 69 | 405.5 ± 463.0 | 38 | 0.0475 |
| ISS | 24.8 ± 14.8 | 72 | 21.1 ± 14.8 | 40 | 0.1927 |
| Survival | 9 yes / 63 no | 72 | 8 yes / 32 no | 40 | 0.4100 |
| Surviving vs. Deceased patients | |||||
| Length of overall hospitalization | 34.2 ± 27.6 | 12.0 ± 18.9 | 17 | < 0.0001 | |
| Haematoma volume (ml) | 650.4 ± 413.7 | 95 | 1093.3 ± 521.9 | 17 | 0.0002 |
| ISS | 21.5 ± 13.7 | 95 | 34.8 ± 16.1 | 17 | 0.0015 |
| Surgical procedures after angiography | 1.1 ± 1.1 | 0.6 ± 1.1 | 17 | 0.072 | |
| Share of microcoils (% of total) | 63.1 ± 46.5 | 89 | 28.5 ± 46.8 | 14 | 0.0078 |
| PTT (s) | 44.7 ± 24.7 | 95 | 71.2 ± 53.4 | 17 | 0.0114 |
| Hb (g/l) | 97.1 ± 26.2 | 95 | 77.6 ± 27.5 | 17 | 0.0123 |
| Microcoils used | 64 yes / 25 no | 89 | 5 yes / 9 no | 14 | 0.0127 |
| Transfusion received (any) | 0.8 ± 0.4 | 95 | 0.9 ± 0.3 | 17 | 0.463 |
| Packed red blood cells | 4.5 ± 6.3 | 95 | 8.8 ± 2.1 | 17 | 0.021 |
| Fresh frozen plasma | 0.3 ± 0.8 | 95 | 1.0 ± 1.4 | 17 | 0.046 |
| Platelet concentrate | 2.8 ± 6.4 | 95 | 5.5 ± 4.2 | 17 | 0.077 |
| Length of microcoils (mm) | 427.5 ± 646.0 | 89 | 227.9 ± 450.8 | 14 | 0.0473 |
| Surgical procedures before angiography | 0.1 ± 0.3 | 95 | 0.2 ± 0.4 | 17 | 0.669 |
| Length of intensive care stay | 19.5 ± 21.9 | 95 | 18.6 ± 20.2 | 17 | 0.741 |
Hb Haemoglobin, ISS Injury Severity Score, PTT Partial thromboplastin time
Regression analysis
| Logistic Regression analysis | Wald | Odds ratio | Sig. |
| Dependent: Survivala | |||
| Hb (g/l) | 3.915 | 1.028 | 0.048 |
| Haematoma volume (ml) | 4.445 | 0.999 | 0.035 |
| Age (years) | 6.249 | 0.941 | 0.012 |
| ISS | 7.361 | 0.933 | 0.035 |
| Dependent: Re-do Angiographya | |||
| Surgery before angiography | 7.508 | 5.533 | 0.006 |
| Dependent: Use of Macrocoilsb | |||
| Hb (g/l) | 0.496 | 0.991 | 0.481 |
| Crossover technique | 0.869 | 0.515 | 0.351 |
| Direct or secondary admission | 1.179 | 0.544 | 0.278 |
| Duration initial CT-angiography (min) | 2.036 | 1.004 | 0.154 |
| Duration accident-angiography (min) | 2.083 | 0.996 | 0.149 |
| Age (years) | 2.239 | 1.024 | 0.135 |
| Arterial calcification | 2.868 | 0.087 | 0.090 |
| Prothrombine time (%) | 2.958 | 0.978 | 0.085 |
| Dependent: Use of Microcoilsa | |||
| Use of macrocoils | 7.100 | 0.251 | 0.008 |
| Transfusion received | 9.519 | 0.239 | 0.002 |
| Dependent: Use of Particlesa | |||
| Surgery before angiography | 3.543 | 0.268 | 0.060 |
| Number of injured arteries | 8.601 | 2.030 | 0.003 |
| Linear Regression analysis | B | β | Sig. (t- Test) |
| Dependent: Duration Trauma to Angiographyc | |||
| OTA classification | −221.298 | −0.189 | 0.047 |
| Anticoagulation | 612.148 | 0.242 | 0.011 |
| Surgery before angiography | 1066.772 | 0.336 | < 0.001 |
| Dependent: Hematomac | |||
| OTA classification | −115.568 | −0.240 | 0.028 |
| ISS | 11.324 | 0.375 | 0.001 |
| Dependent: Duration of Angiography and TAEc | |||
| Use of particles | −19.256 | −0.214 | 0.024 |
| ISS | −0.639 | −0.215 | 0.019 |
| Number of injured arteries | 17.149 | 0.346 | < 0.001 |
| Dependent: Hospitalizationc | |||
| Duration of angiography | 0.108 | 0.172 | 0.018 |
| ISS | 0.736 | 0.398 | < 0.001 |
| Number of macrocoils used | 0.807 | 0.149 | 0.039 |
| Crossover technique | 17.280 | 0.216 | 0.004 |
| Re-do angiography | 30.730 | 0.394 | < 0.001 |
| Survival | 35.369 | 0.442 | < 0.001 |
Hb Haemoglobin, ISS Injury Severity Score, OTA Orthopaedic Trauma Association
aForward stepwise method
bEnter method
cStepwise method
Comparison of propensity-score-matched patient groups
| Deceased patients | Surviving patients | Re-do Angiography | No re-do Angiography | Surgical procedures before Angiography | No surgery before Angiography | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fisher’s exact test |
|
|
|
|
|
|
|
|
| ||||||||||||
| Gender | 7 m | 8 f | 15 | 16 m | 13 f | 29 | 0.752 | 11 m | 5 f | 16 | 22 m | 10 f | 32 | 1.000 | 11 m | 4 f | 15 | 22 m | 8 f | 30 | 1.000 |
| Surgical procedures | 3 y | 12 n | 15 | 1 y | 28 n | 29 | 0.107 | 6 y | 10 n | 16 | 5 y | 27 n | 32 | 0.144 | - | - | - | - | - | - | - |
| Direct or secondary admission | 9 y | 6 n | 15 | 15 y | 14 n | 29 | 0.752 | 6 y | 10 n | 16 | 12 y | 20 n | 32 | 1.000 | 7 y | 8 n | 15 | 20 y | 10 n | 30 | 0.218 |
| Transfusion received | 13 y | 2 n | 15 | 16 y | 13 n | 29 | 0.010 | 11 y | 5 n | 16 | 17 y | 15 n | 32 | 0.363 | 11 y | 4 n | 15 | 17 y | 13 n | 30 | 0.341 |
| Oral anticoagulation | 4 y | 11 n | 15 | 10 y | 19 n | 29 | 0.738 | 3 y | 13 n | 16 | 5 y | 27 n | 32 | 1.000 | 2 y | 13 n | 15 | 6 y | 24 n | 30 | 0.699 |
| Microcoils used | 5 y | 10 n | 15 | 26 y | 3 n | 29 | 0.000 | 10 y | 6 n | 16 | 19 y | 13 n | 32 | 1.000 | 6 y | 9 n | 15 | 18 y | 12 n | 30 | 0.226 |
| Macrocoils used | 3 y | 12 n | 15 | 4 y | 25 n | 29 | 0.675 | 5 y | 11 n | 16 | 6 y | 26 n | 32 | 0.468 | 4 y | 11 n | 15 | 6 y | 24 n | 30 | 0.710 |
| Particles used | 8 y | 7 n | 15 | 12 y | 17 n | 29 | 0.532 | 3 y | 13 n | 16 | 15 y | 17 n | 32 | 0.068 | 3 y | 12 n | 15 | 14 y | 16 n | 30 | 0.110 |
| Re-do angiography | 2 y | 13 n | 15 | 6 y | 23 n | 29 | 0.695 | - | - | - | - | - | - | - | 6 y | 9 n | 15 | 6 y | 24 n | 30 | 0.174 |
| Deceased | - | - | - | - | - | - | - | 2 y | 14 n | 16 | 5 y | 27 n | 32 | 1.000 | 3 y | 12 n | 15 | 5 r | 25 l | 30 | 1.000 |
| Mann-Whitney Test |
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
| Patient age (years) | 61.8 ± 17.1 | 15 | 63.3 ± 19.0 | 29 | 0.718 | 55.8 ± 21.5 | 16 | 54.5 ± 21.1 | 32 | 0.910 | 55.9 ± 17.9 | 15 | 52.9 ± 20.9 | 30 | 0.690 | ||||||
| Accident till angiography (min) | 287.8 ± 212.4 | 15 | 582.6 ± 725.8 | 29 | 0.752 | 976.9 ± 2011.7 | 16 | 546.3 ± 1054.3 | 32 | 0.774 | 1374.0 ± 2450.5 | 15 | 365.0 ± 447.1 | 30 | 0.035 | ||||||
| CT till angiography (min) | 192.7 ± 216.8 | 15 | 422.7 ± 655.9 | 29 | 0.194 | 692.4 ± 2072.1 | 16 | 234.6 ± 236.2 | 32 | 0.261 | 853.5 ± 2145.3 | 15 | 202.5 ± 273.0 | 30 | 0.387 | ||||||
| Duration angiography (min) | 74.2 ± 51.0 | 15 | 89.2 ± 57.4 | 29 | 0.561 | 78.9 ± 44.8 | 16 | 76.5 ± 43.9 | 32 | 0.935 | 84.9 ± 56.6 | 15 | 71.7 ± 41.9 | 30 | 0.428 | ||||||
| HB (g/l) | 77.0 ±29.3 | 15 | 94.6 ± 19.7 | 29 | 0.036 | 82.0 ± 28.5 | 16 | 95.9 ± 24.4 | 32 | 0.087 | 89.5 ± 25.1 | 15 | 86.4 ± 26.5 | 30 | 0.919 | ||||||
| PTT (s) | 70.7 ± 57.1 | 15 | 44.4 ± 13.7 | 29 | 0.185 | 56.2 ± 29.6 | 16 | 52.6 ± 43.2 | 32 | 0.117 | 62.5 ± 57.0 | 15 | 55.1 ± 37.4 | 30 | 0.919 | ||||||
| Quick (%) | 55.2 ±29.2 | 15 | 61.9 ± 26.7 | 29 | 0.496 | 59.1 ± 23.6 | 16 | 67.6 ± 26.1 | 32 | 0.315 | 65.3 ± 29.0 | 15 | 61.3 ± 24.3 | 30 | 0.734 | ||||||
| No. of arteries injured | 2.4 ± 1.1 | 15 | 2.3 ± 1.0 | 29 | 0.955 | 1.8 ± 0.8 | 16 | 1.8 ± 1.0 | 32 | 0.724 | 1.8 ± 0.8 | 15 | 1.7 ± 0.8 | 30 | 0.598 | ||||||
| Overall coil length (mm) | 393.0 ± 536.6 | 15 | 704.3 ±627.6 | 29 | 0.035 | 584.4 ± 794.9 | 16 | 352.0 ± 459.4 | 32 | 0.220 | 297.3 ± 463.4 | 15 | 485.7 ± 684.6 | 30 | 0.147 | ||||||
| Overall No. of coils | 7.0 ± 7.6 | 15 | 12.7 ± 7.8 | 29 | 0.017 | 9.2 ± 8.1 | 16 | 6.7 ± 8.1 | 32 | 0.220 | 5.5 ± 8.3 | 15 | 6.9 ± 5.8 | 30 | 0.120 | ||||||
| ISS | 35.2 ± 17.1 | 15 | 22.8 ± 14.6 | 29 | 0.024 | 28.5 ± 13.7 | 16 | 20.8 ± 14.2 | 32 | 0.061 | 26.5 ± 13.4 | 15 | 27.7 ± 17.3 | 30 | 0.948 | ||||||
| OTA classification | 2.3 ± 0.8 | 15 | 2.3 ± 0.8 | 29 | 0.760 | 2.4 ± 0.7 | 16 | 1.9 ± 1.0 | 32 | 0.063 | 2.5 ± 0.9 | 15 | 2.1 ± 0.9 | 30 | 0.189 | ||||||
| Arterial calcification (cm3) | 0.49 ± 0.89 | 15 | 0.39 ± 1.14 | 29 | 0.656 | 0.27 ± 0.43 | 16 | 0.28 ± 1.1 | 32 | 0.968 | 0.11 ± 0.18 | 15 | 0.19 ± 0.36 | 30 | 0.902 | ||||||
| Haematoma volume (ml) | 1031.3 ± 517.8 | 15 | 518.2 ± 258.0 | 29 | 0.000 | 770.9 ± 370.1 | 16 | 739.8 ± 454.9 | 32 | 0.638 | 887.9 ± 497.6 | 15 | 584.4 ± 334.6 | 30 | 0.061 | ||||||
| Share of fibered coils (%) | 29.4 ± 44.5 | 15 | 50.1 ± 43.6 | 29 | 0.140 | 55.8 ± 42.3 | 16 | 44.6 ± 48.4 | 32 | 0.339 | 41.3 ± 49.8 | 15 | 45.1 ± 47.1 | 30 | 0.692 | ||||||
| Hospitalization (days) | 10.4 ± 17.4 | 15 | 35.9 ± 29.6 | 29 | 0.000 | 63.1 ± 31.9 | 16 | 19.9 ± 19.0 | 32 | 0.000 | 40.3 ± 28.2 | 15 | 26.9 ± 19.7 | 30 | 0.181 | ||||||
| Overall coil length (mm) | 393.0 ± 536.6 | 15 | 704.3 ±627.6 | 29 | 0.035 | 584.4 ± 794.9 | 16 | 352.0 ± 459.4 | 32 | 0.220 | 297.3 ± 463.4 | 15 | 485.7 ± 684.6 | 30 | 0.147 | ||||||
| Overall No. of coils | 7.0 ± 7.6 | 15 | 12.7 ± 7.8 | 29 | 0.017 | 9.2 ± 8.1 | 16 | 6.7 ± 8.1 | 32 | 0.220 | 5.5 ± 8.3 | 15 | 6.9 ± 5.8 | 30 | 0.120 | ||||||
| No. of microcoils used | 4.1 ± 6.9 | 15 | 11.2 ± 8.2 | 29 | 0.002 | 5.7 ± 7.3 | 16 | 5.8 ± 7.4 | 32 | 0.906 | 2.9 ± 4.8 | 15 | 4.9 ± 5.8 | 30 | 0.212 | ||||||
| No. of macrocoils used | 2.9 ± 6.0 | 15 | 1.5 ± 8.2 | 29 | 0.487 | 3.5 ± 6.9 | 16 | 0.9 ± 2.5 | 32 | 0.140 | 2.5 ± 6.0 | 15 | 2.0 ± 4.1 | 30 | 0.461 | ||||||